Mauro Gacci

Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis

C. Gaudio, M. Tubaro, A. Tubaro, 2015, Prostate Cancer and Prostatic Disease.

Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO)

C. Gratzke, K. Tikkinen, S. Gravas, 2019 .

PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH

M. Carini, S. Kaplan, K. McVary, 2013, Current Bladder Dysfunction Reports.

The prevalence of midline prostatic cysts and the relationship between cyst size and semen parameters among infertile and fertile men

E. Baldi, A. Cocci, M. Gacci, 2018, Human reproduction.

Unveiling prostatic inflammation to optimize management of lower urinary tract symptoms: a discussion with experts.

C. Nunzio, Mauro Gacci, Stavros Gravas, 2023, Biomarkers in medicine.

Prostatic inflammation: a potential treatment target for male LUTS due to benign prostatic obstruction

A. De la taille, A. Taille, M. Gacci, 2018, Prostate Cancer and Prostatic Diseases.

Review – Benign Prostatic Hyperplasia – Editor’s Choice Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms

M. Karavitakis, K. Tikkinen, I. Kyriazis, 2022 .

Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view.

C. Nanni, S. Fanti, M. Borghesi, 2013, Revista espanola de medicina nuclear e imagen molecular.